CryoPort Inc

NASDAQ:CYRX

7.66

+0.22 (+2.96%)

4:35:24 PM EDT: $7.67 +0.01 (+0.12%)

Market Cap (Intraday)	395.42M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$41.74 Million
Adjusted EPS	-$0.27

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

CryoPort Inc Stock, NASDAQ:CYRX

112 Westwood Place, Suite 350, Brentwood, Tennessee 37027

United States of America

Phone: +1.949.470.2305

Number of Employees: 1170

http://www.cryoport.com

Description

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.